Jump to content

25I-NB34MD

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Mario Castelán Castro (talk | contribs) at 02:18, 28 August 2016 (Fix IUPAC name. Add navboxes and categories. Remove section “see also” (redundant with navboxes).). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

25I-NB34MD
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
  • N-[(2H-1,3-Benzodioxol-5-yl)methyl]-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine
CAS Number
Chemical and physical data
FormulaC18H20INO4
Molar mass441.259 g/mol g·mol−1
3D model (JSmol)
  • O1C2=C(OC1)C=C(C=C2)CNCCC3=C(C=C(C(=C3)OC)I)OC
  • InChI=1S/C18H20INO4/c1-21-16-9-14(19)17(22-2)8-13(16)5-6-20-10-12-3-4-15-18(7-12)24-11-23-15/h3-4,7-9,20H,5-6,10-11H2,1-2H3 checkY
  • Key:FWEBGKDUEZRMRQ-UHFFFAOYSA-N checkY

25I-NB34MD (NB34MD-2C-I) is a derivative of the phenethylamine hallucinogen 2C-I, which acts as a potent partial agonist for the human 5-HT2A receptor, and presumably has similar properties to 2C-I.[1] It has a binding affinity of 0.67nM at the human 5-HT2A receptor, maing it several times weaker than its positional isomer 25I-NBMD and a similar potency to 25I-NBF.[2][3]

Legality

25I-NB34MD is illegal in Hungary,[4] Japan,[5] and Sweden.[6]

References

  1. ^ Nahoko Uchiyama; Ruri Kikura-Hanajiri; Takashi Hakamatsuka (January 2016). "A phenethylamine derivative 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(3,4-methylenedioxyphenyl)methyl]ethanamine (25I-NB34MD) and a piperazine derivative 1-(3,4-difluoromethylenedioxybenzyl)piperazine (DF-MDBP), newly detected in illicit products". Forensic Toxicology. 34 (1): 166–173. doi:10.1007/s11419-015-0304-7.
  2. ^ Braden, MR; Parrish, JC; Naylor, JC; Nichols, DE (December 2006). "Molecular Interaction of Serotonin 5-HT2A Receptor Residues Phe339(6.51) and Phe340(6.52) with Superpotent N-Benzyl Phenethylamine Agonists". Molecular Pharmacology. 70 (6): 1956–1964. doi:10.1124/mol.106.028720. PMID 17000863.
  3. ^ Michael Robert Braden (2007). "Towards a biophysical understanding of hallucinogen action". Dissertation. Purdue University.
  4. ^ A Magyarországon megjelent, a Kábítószer és Kábítószer-függőség Európai Megfigyelő Központjának Korai Jelzőrendszerébe (EMCDDA EWS) 2005 óta bejelentett ellenőrzött anyagok büntetőjogi vonatkozású besorolása
  5. ^ "指定薬物名称・構造式一覧(平成27年9月16日現在)" (PDF) (in Japanese). 厚生労働省. 16 September 2015. Retrieved 8 October 2015.
  6. ^ List of substances to be considered narcotics according to the Narcotic Drugs Punishments Act, 2015